Loading…

Site-selective superassembly of biomimetic nanorobots enabling deep penetration into tumor with stiff stroma

Chemotherapy remains as the first-choice treatment option for triple-negative breast cancer (TNBC). However, the limited tumor penetration and low cellular internalization efficiency of current nanocarrier-based systems impede the access of anticancer drugs to TNBC with dense stroma and thereby grea...

Full description

Saved in:
Bibliographic Details
Published in:Nature communications 2023-08, Vol.14 (1), p.4628-4628, Article 4628
Main Authors: Yan, Miao, Chen, Qing, Liu, Tianyi, Li, Xiaofeng, Pei, Peng, Zhou, Lei, Zhou, Shan, Zhang, Runhao, Liang, Kang, Dong, Jian, Wei, Xunbin, Wang, Jinqiang, Terasaki, Osamu, Chen, Pu, Gu, Zhen, Jiang, Libo, Kong, Biao
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Chemotherapy remains as the first-choice treatment option for triple-negative breast cancer (TNBC). However, the limited tumor penetration and low cellular internalization efficiency of current nanocarrier-based systems impede the access of anticancer drugs to TNBC with dense stroma and thereby greatly restricts clinical therapeutic efficacy, especially for TNBC bone metastasis. In this work, biomimetic head/hollow tail nanorobots were designed through a site-selective superassembly strategy. We show that nanorobots enable efficient remodeling of the dense tumor stromal microenvironments (TSM) for deep tumor penetration. Furthermore, the self-movement ability and spiky head markedly promote interfacial cellular uptake efficacy, transvascular extravasation, and intratumoral penetration. These nanorobots, which integrate deep tumor penetration, active cellular internalization, near-infrared (NIR) light-responsive release, and photothermal therapy capacities into a single nanodevice efficiently suppress tumor growth in a bone metastasis female mouse model of TNBC and also demonstrate potent antitumor efficacy in three different subcutaneous tumor models. Limited tumor penetration and low cellular uptake of current nanocarriers reduce the efficacy of anticancer drugs against TNBC. Here the authors develop biomimetic head/hollow tail nanorobots and show their efficacy at remodeling the dense tumor stroma in TNBC.
ISSN:2041-1723
2041-1723
DOI:10.1038/s41467-023-40300-2